Drug therapy. Treatment of common parasitic infections of man encountered in the United States. 2.
D000562:Amebiasis / Q000188:drug therapy; D000563:Amebicides / Q000627:therapeutic use; D000871:Anthelmintics / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D000965:Antimony / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003003:Clonorchiasis / Q000188:drug therapy; D003004:Clonorchis sinensis; D004404:Dysentery, Amebic / Q000188:drug therapy; D005873:Giardiasis / Q000188:drug therapy; D006801:Humans; D004103:Iodoquinol / Q000627:therapeutic use; D008101:Liver Abscess, Amebic / Q000188:drug therapy; D008288:Malaria / Q000188:drug therapy; D008795:Metronidazole / Q000627:therapeutic use; D009560:Niridazole / Q000627:therapeutic use; D011528:Protozoan Infections / Q000188:drug therapy*; D011796:Quinacrine / Q000627:therapeutic use; D012548:Schistosoma haematobium; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000188:drug therapy; D013644:Tartrates / Q000627:therapeutic use; D014201:Trematode Infections / Q000188:drug therapy*
D000563:Amebicides; D000871:Anthelmintics; D000962:Antimalarials; D001557:Benzenesulfonates; D013644:Tartrates; D008795:Metronidazole; D004103:Iodoquinol; D002738:Chloroquine; D000965:Antimony; D011796:Quinacrine; D009560:Niridazole